Juliane Hörner‐Rieber

Author

Heidelberg University ORCID

Also Known As

Hörner-Rieber, Juliane, J Hörner-Rieber, J. Hörner-Rieber, Juliane Hörner-Rieber, Juliane Hörner‐Rieber

286

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center National Center for Tumor Diseases Heidelberger Institut für Radioonkologie

About

Juliane Hörner‐Rieber is an author at Heidelberg University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	586
2	Health Sciences	12	13	344
3	Nursing	1	1	12
4	Hepatology	1	1	23
5	Obstetrics	1	1	12

Juliane Hörner‐Rieber

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments Rainer J. Klement, Jan‐Jakob Sonke, Michael Allgäuer, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyIndividual TreatmentsRadiation TherapyMedicineRadiation Therapy Planning	2020	69
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology Stefanie Corradini, Filippo Alongi, Nicolaus Andratschke, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineMedical ImagingRadiation TherapyTreatment Verification	2021	64
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial) Juliane Hörner‐Rieber, Tobias Förster, Adriane Hommertgen, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation MedicineOncologyRadiation TherapyIs Noninferior	2020	57
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients Laila König, Matthias Häfner, Sonja Katayama, Radiation Oncology	2020	56
<p>Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis</p> Rami A. El Shafie, Karina Böhm, Dorothea Weber, Cancer Management and Research	2019	55
First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany Sebastian Klüter, Sonja Katayama, C.K. Spindeldreier, Strahlentherapie und Onkologie	2020	55
Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response Rami A. El Shafie, Karina Böhm, Dorothea Weber, Frontiers in Oncology	2019	54
A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy Sebastian Klüter, Oliver Schrenk, C. Katharina Renkamp, Physics and Imaging in Radiation Oncology	2021	50
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy Juliane Hörner‐Rieber, Denise Bernhardt, Julian Dern, Radiotherapy and Oncology Adaptive RadiotherapyRadiation TherapyMedicinePathologyStereotactic Body Radiotherapy	2017	47
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT Juliane Hörner‐Rieber, Denise Bernhardt, Oliver Blanck, Clinical Lung Cancer Oligometastatic Nsclc TreatedAdvanced Lung DiseasePulmonary SbrtSurgeryMedicine	2019	45

Page 1